ASCEPT, APFP & APSA Joint Congress 2024

이벤트:

Novotech will participate in the inaugural joint congress hosted by the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), the Asia Pacific Federation of Pharmacologists (APFP), and the Australasian Pharmaceutical Science Association (APSA) in Melbourne, Australia from December 1-4, 2024. The congress will bring together professionals across pharmacology, toxicology, pharmaceutical sciences, and clinical sciences. 

Join us at Novotech’s table to connect with our Drug Discovery Consulting Group, which provides end-to-end support from discovery to registration: 

Felicity Grzemski, Toxicology Director. 

Karen Scalzo-Inguanti, Senior Therapeutics Strategy Manager. 

Sharleen Menezes, Senior Toxicologist. 

Melisa Anggraeni, Senior Scientific Consultant. 

Melissa Dworak, Toxicologist. 

Presentations: 

• Navigating the Valley of Threats: Bringing a Potential Therapeutic from Candidate to the Clinic 

When: Sunday, Dec. 1, 11:15 – 1:15 in Eureka Room 2. 

Presented by Karen Scalzo-Inguanti and Melisa Anggraeni. 

• Poster Presentation: Navigating the Challenges of Cell and Gene Therapies - Nonclinical and Manufacturing Considerations 

Dr. Sharleen Menezes’ poster will be on display from December 2-4, under the Innovation and Industry theme, Paper #181. Sharleen will present on her poster: 

• Monday, Dec. 2: 10:30 - 11:10 and 13:15 - 14:10. 
• Tuesday, Dec. 3: 10:30 - 11:10 and 13:15 - 14:10. 
• Wednesday, Dec. 4: 09:50 - 10:25, with student poster finalists from 12:30 – 13:25.